Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$209.01 - $232.56 $67,301 - $74,884
-322 Reduced 14.73%
1,864 $407,000
Q4 2023

Feb 14, 2024

SELL
$197.69 - $227.29 $26,490 - $30,456
-134 Reduced 5.78%
2,186 $496,000
Q3 2023

Nov 14, 2023

BUY
$201.05 - $221.7 $40,008 - $44,118
199 Added 9.38%
2,320 $466,000
Q2 2023

Aug 14, 2023

BUY
$211.93 - $241.33 $25,007 - $28,476
118 Added 5.89%
2,121 $511,000
Q1 2023

May 15, 2023

BUY
$213.32 - $257.83 $14,292 - $17,274
67 Added 3.46%
2,003 $459,000
Q4 2022

Feb 13, 2023

SELL
$203.72 - $248.97 $86,988 - $106,310
-427 Reduced 18.07%
1,936 $455,000
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $52,226 - $66,858
255 Added 12.1%
2,363 $483,000
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $29,512 - $38,346
-138 Reduced 6.14%
2,108 $494,000
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $442,993 - $508,396
1,705 Added 315.16%
2,246 $592,000
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $146,935 - $169,987
541 New
541 $169,000
Q3 2021

Feb 05, 2024

SELL
$274.82 - $308.34 $159,670 - $179,145
-581 Reduced 25.04%
1,739 $489 Million
Q2 2021

Jan 08, 2024

BUY
$251.87 - $278.14 $9,319 - $10,291
37 Added 3.05%
1,252 $345 Million
Q1 2021

Jan 08, 2024

BUY
$204.88 - $255.03 $248,929 - $309,861
1,215 New
1,215 $310 Million
Q2 2020

Jan 08, 2024

SELL
$113.31 - $182.44 $282,368 - $454,640
-2,492 Closed
0 $0
Q1 2020

Jan 08, 2024

BUY
$104.32 - $195.28 $2,503 - $4,686
24 Added 0.97%
2,492 $315 Million
Q4 2019

Jan 30, 2024

BUY
$163.48 - $173.61 $24,195 - $25,694
148 Added 6.38%
2,468 $418 Million
Q4 2019

Jan 08, 2024

SELL
$163.48 - $173.61 $2.52 Million - $2.68 Million
-15,432 Reduced 86.21%
2,468 $418 Million
Q3 2019

Jan 08, 2024

BUY
$159.77 - $178.1 $2.49 Million - $2.77 Million
15,580 Added 671.55%
17,900 $30.1 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.4B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Snowden Capital Advisors LLC Portfolio

Follow Snowden Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Snowden Capital Advisors LLC with notifications on news.